Preoperative hyperfractionated radiotherapy with concurrent chemotherapy in resectable esophageal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 1, 2001, Pages 1-12

  Martinez, Jose Carlos ^a   Villar, Alfonso ^a,b   Cabezon, Maria Auxiliadora ^a   De Serdio, Jose Luis ^a   Fuentes, Claudio ^a   Espieira, Manuel ^a   Perez, Maria Dolores ^a   Gil, Jose ^a   Artazkoz, Juan Jose ^a   Borque, Carlos ^a   Suer, Marcos ^a   Saavedra, Juan Antonio ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b Servicio de Oncologia Radioterapica   (Spain)

Author keywords

Chemotherapy; Esophageal carcinoma; Multidisciplinary treatment; Radiotherapy; Surgery

Indexed keywords

CHEMOTHERAPY; DISEASES; TUMORS;

CONCURRENT CHEMOTHERAPY; HYPERFRACTIONATED RADIOTHERAPY;

RADIOTHERAPY;

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PATIENT COMPLIANCE; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REMISSION; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT FAILURE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LEUKOPENIA; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREOPERATIVE CARE; RADIATION INJURIES; RADIOTHERAPY; SURVIVAL RATE;

EID: 0035341338     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01459-6     Document Type: Article

References (24)

1. Combined chemo-therapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
2. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus; A study of the eastern cooperative oncology group
3. Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal cancer
4. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus; Final report
5. Nonoperative therapy for squamous-cell cancer of the esophagus
6. Combined modality therapy for esophageal squamous cell carcinoma
7. Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060
8. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma
9. Preoperative therapy with paclitaxel, carboplatin, 5-FU and radiation yields 69% pathologic complete response (CR) rate in the treatment of local esophageal carcinoma
10. Pre-operative radiotherapy, and chemotherapy in epidermoid oesophageal cancers. Results of a phase II multicentric trial by the French Foundation for Carcinology of the digestive tract (FFCD)
11. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma. A randomized, multicenter study of preoperative radio-therapy and chemotherapy. The second Scandinavian trial in esophageal cancer
12. Preoperative concomitant radiochemotherapy in squamous cell carcinoma of the esophagus; Results of a study of 56 patients
13. Neoadjuvant chemotherapy for squamous cell esophageal carcinoma
14. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus
15. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
16. A randomized trial comparing surgery (S) to preoperative concomitant chemoradiation plus surgery in patients (pts) with resectable esophageal cancer (CA); Updated analysis
17. A phase I/II trial of preoperative Taxol (T), 5-FU (F) and concurrent boost radiation (XRT) in esophageal cancer
18. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus
19. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus; A RTOG study
20. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07); Preliminary toxicity report
21. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990
22. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma